A highly sensitive and specific genetic marker to diagnose aspirin-exacerbated respiratory disease using a genome-wide association study

DNA and Cell Biology

Volumn 31, Issue 11, 2012, Pages 1604-1609

  Shin, Seung Woo ^a   Park, Jongsook ^a   Kim, Yoon Jeong ^a   Uh, Soo Taek ^a   Choi, Byoung Whui ^b   Kim, Mi Kyeong ^c   Choi, Inseon S ^d   Park, Byung Lae ^e   Shin, Hyoungdoo ^f   Park, Choon Sik ^a  

^a Soonchunhyang University   (South Korea)

^b Chung Ang University   (South Korea)

^c Chungbuk National University   (South Korea)

^d Chonnam National University   (South Korea)

^e Chonnam National University ^*  (South Korea)

^f Sogang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ADOLESCENT; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN TOLERANT ASTHMA; ASTHMA; FEMALE; GENETIC ASSOCIATION; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; ALLELES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; ASTHMA, ASPIRIN-INDUCED; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; ROC CURVE; SOFTWARE; YOUNG ADULT;

EID: 84868009221     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2012.1688     Document Type: Article

References (41)

1. Bateman, E.D., Hurd, S.S., Barnes, P.J., Bousquet, J., Drazen, J.M., FitzGerald, M., Gibson, P., Ohta, K., O'Byrne, P., Pedersen, S.E., Pizzichini, E., Sullivan, S.D., Wenzel, S.E., and Zar, H.J. (2008). Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31, 143-178.
2. Blanco, S., Sanz-Garcia, M., Santos, C.R., and Lazo, P.A. (2008). Modulation of interleukin-1 transcriptional response by the interaction between VRK2 and the JIP1 scaffold protein. PLoS One 3, e1660.
3. Bouman, L., Schlierf, A., Lutz, A.K., Shan, J., Deinlein, A., Kast, J., Galehdar, Z., Palmisano, V., Patenge, N., Berg, D., Gasser, T., Augustin, R., Trumbach, D., Irrcher, I., Park, D.S., Wurst, W., Kilberg, M.S., Tatzelt, J., and Winklhofer, K.F. (2011). Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ 18, 769-782.
4. Chang, H.S., Park, J.S., Jang, A.S., Park, S.W., Uh, S.T., Kim, Y.H., and Park, C.S. (2011). Diagnostic value of clinical parameters in the prediction of aspirin-exacerbated respiratory disease in asthma. Allergy Asthma Immunol Res 3, 256-264.
5. Choi, J.H., Park, H.S., Oh, H.B., Lee, J.H., Suh, Y.J., Park, C.S., and Shin, H.D. (2004). Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114, 337-344.
6. Christopher, A., Haiman, Loic Le Marchand, Jennifer, Yamamato, Daniel, O., Stram, Xin, Sheng, Laurence, N., Kolonel, Anna, H., Wu, David, Reich, Brian, E., and Henderson. (2007). A common genetic risk factor for colorectal and prostate cancer. Nature Genetics 39, 954-956.
7. Cornfield, J. (1951). A method for estimating comparative rates from clinical data. Applications to cancer of the lung, breast, and cervix. J Natl Cancer Inst 11, 1269-1275.
8. De Weck, A.L., Sanz, M.L., Gamboa, P.M., Jermann, J.M., Kowalski, M., Medrala, W., Sainte-Laudy, J., Schneider, M.S., Weber, J.M., and Wolanczyk-Medrala, A. (2010). Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal antiinflammatory drugs and its impact on pathogenesis. J Investig Allergol Clin Immunol 20, 39-57.
9. Devouassoux, G., Pachot, A., Laforest, L., Diasparra, J., Freymond, N., Van Ganse, E., Mougin, B., and Pacheco, Y. (2008). Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy 63, 125-131.
10. Douglas, F., Easton, and Rosalind, A. Eeles, (2008). Genome-wide association studies in cancer. Hum Mol Genet 17, R109-R115.
11. Gollapudi, R.R., Teirstein, P.S., Stevenson, D.D., and Simon, R.A. (2004). Aspirin sensitivity: implications for patients with coronary artery disease. JAMA 292, 3017-3023.
12. Gudbjartsson, D.F., Bjornsdottir, U.S., Halapi, E., Helgadottir, A., Sulem, P., Jonsdottir, G.M., Thorleifsson, G., Helgadottir, H., Steinthorsdottir, V., Stefansson, H., Williams, C., Hui, J., Beilby, J., Warrington, N.M., James, A., Palmer, L.J., Koppelman, G.H., Heinzmann, A., Krueger, M., Boezen, H.M., Wheatley, A., Altmuller, J., Shin, H.D., Uh, S.T., Cheong, H.S., Jonsdottir, B., Gislason, D., Park, C.S., Rasmussen, L.M., Porsbjerg, C., Hansen, J.W., Backer, V., Werge, T., Janson, C., Jonsson, U.B., Ng, M.C., Chan, J., So, W.Y., Ma, R., Shah, S.H., Granger, C.B., Quyyumi, A.A., Levey, A.I., Vaccarino, V., Reilly, M.P., Rader, D.J., Williams, M.J., van Rij, A.M., Jones, G.T., Trabetti, E., Malerba, G., Pignatti, P.F., Boner, A., Pescollderungg, L., Girelli, D., Olivieri, O., Martinelli, N., Ludviksson, B.R., Ludviksdottir, D., Eyjolfsson, G.I., Arnar, D., Thorgeirsson, G., Deichmann, K., Thompson, P.J., Wjst, M., Hall, I.P., Postma, D.S., Gislason, T., Gulcher, J., Kong, A., Jonsdottir, I., Thorsteinsdottir, U., and Stefansson, K. (2009). Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41, 342-347.
13. Himes, B.E., Hunninghake, G.M., Baurley, J.W., Rafaels, N.M., Sleiman, P., Strachan, D.P., Wilk, J.B., Willis-Owen, S.A., Klanderman, B., Lasky-Su, J., Lazarus, R., Murphy, A.J., Soto- Quiros, M.E., Avila, L., Beaty, T., Mathias, R.A., Ruczinski, I., Barnes, K.C., Celedon, J.C., Cookson, W.O., Gauderman, W.J., Gilliland, F.D., Hakonarson, H., Lange, C., Moffatt, M.F., O'Connor, G.T., Raby, B.A., Silverman, E.K., and Weiss, S.T. (2009). Genome-wide association analysis identifies PDE4D as an asthma-susceptibility gene. Am J Hum Genet 84, 581-593.
14. Hirschhorn, J.N., and Daly, M.J. (2005). Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 6, 95-108.
15. Jun, Zhang, M.B., Kai, F., and Yu. (1998). What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280, 1690-1691.
16. Kim, B.S., Park, S.M., Uhm, T.G., Kang, J.H., Park, J.S., Jang, A.S., Uh, S.T., Kim, M.K., Choi, I.S., Cho, S.H., Hong, C.S., Lee, Y.W., Lee, J.Y., Choi, B.W., Park, H.S., Park, B.L., Shin, H.D., Chung, I.Y., and Park, C.S. (2010). Effect of single nucleotide polymorphisms within the interleukin-4 promoter on aspirin intolerance in asthmatics and interleukin-4 promoter activity. Pharmacogenet Genomics 20, 748-758.
17. Kim, J.H., Park, B.L., Cheong, H.S., Bae, J.S., Park, J.S., Jang, A.S., Uh, S.T., Choi, J.S., Kim, Y.H., Kim, M.K., Choi, I.S., Cho, S.H., Choi, B.W., Park, C.S., and Shin, H.D. (2010). Genome-wide and follow-up studies identify CEP68 gene variants associated with risk of aspirin-intolerant asthma. PLoS One 5, e13818.
18. Kim, S.H., Choi, J.H., Park, H.S., Holloway, J.W., Lee, S.K., Park, C.S., and Shin, H.D. (2005). Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 35, 585-590.
19. Kim, T.H., Chang, H.S., Park, S.M., Nam, B.Y., Park, J.S., Rhim, T., Park, H.S., Kim, M.K., Choi, I.S., Cho, S.H., Chung, I.Y., Park, B.L., Park, C.S., and Shin, H.D. (2008). Association of angiotensin I-converting enzyme gene polymorphisms with aspirin intolerance in asthmatics. Clin Exp Allergy 38, 1727-1737.
20. Kraft, P., Wacholder, S., Cornelis, M.C., Hu, F.B., Hayes, R.B., Thomas, G., Hoover, R., Hunter, D.J., and Chanock, S. (2009). Beyond odds ratios-communicating disease risk based on genetic profiles. Nat Rev Genet 10, 264-269.
21. Lee, R., and Stevenson, D. (2011). Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 3, 3-10.
22. Lee, S.H., Rhim, T., Choi, Y.S., Min, J.W., Kim, S.H., Cho, S.Y., Paik, Y.K., and Park, C.S. (2006). Complement C3a and C4a increased in plasma of patients with aspirin-induced asthma. Am J Respir Crit Care Med 173, 370-378.
23. Marquette, C.H., Saulnier, F., Leroy, O., Wallaert, B., Chopin, C., Demarcq, J.M., Durocher, A., and Tonnel, A.B. (1992). Longterm prognosis of near-fatal asthma. A 6-year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis 146, 76-81.
24. Mascia, K., Haselkorn, T., Deniz, Y.M., Miller, D.P., Bleecker, E.R., and Borish, L. (2005). Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol 116, 970-975.
25. Min, J.W., Jang, A.S., Park, S.M., Lee, S.H., Lee, J.H., Park, S.W., and Park, C.S. (2005). Comparison of plasma eotaxin family level in aspirin-induced and aspirin-tolerant asthma patients. Chest 128, 3127-3132.
26. Moffatt, M.F., Kabesch, M., Liang, L., Dixon, A.L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., Heinzmann, A., Simma, B., Frischer, T., Willis-Owen, S.A., Wong, K.C., Illig, T., Vogelberg, C., Weiland, S.K., von Mutius, E., Abecasis, G.R., Farrall, M., Gut, I.G., Lathrop, G.M., and Cookson, W.O. (2007). Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448, 470-473.
27. Oh, S.H., Park, S.M., Park, J.S., Jang, A.S., Lee, Y.M., Uh, S.T., Kim, Y.H., Choi, I.S., Kim, M.K., Park, B.L., Shin, H.D., and Park, C.S. (2009). Association analysis of peroxisome proliferator- activated receptors gamma gene polymorphisms with aspirin hypersensitivity in asthmatics. Allergy Asthma Immunol 1, 30-35.
28. Park, B.L., Park, S.M., Park, J.S., Uh, S.T., Choi, J.S., Kim, Y.H., Kim, M.K., Choi, I.S., Choi, B.W., Cho, S.H., Hong, C.S., Lee, Y.W., Lee, J.Y., Park, C.S., and Shin, H.D. (2010). Association of PTGER gene family polymorphisms with aspirin intolerant asthma in Korean asthmatics. BMB Rep 43, 445-449.
29. Park, J.S., Chang, H.S., Park, C.S., Lee, J.H., Lee, Y.M., Choi, J.H., Park, H.S., Kim, L.H., Park, B.L., Choi, Y.H., and Shin, H.D. (2005). Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15, 483-492.
30. Picado, C., Castillo, JA., Montserrat, JM., and Agusti-Vidal, A. (1989). Aspirin-intolerance as a precipitating factor of lifethreatening attacks of asthma requiring mechanical ventilation. Eur Respir 2, 127-129.
31. Plant, D., Bowes, J., Potter, C., Hyrich, K.L., Morgan, A.W., Wilson, A.G., Isaacs, J.D., and Barton, A. (2011). Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum 63, 645-653.
32. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., et al. (2007). PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559-575.
33. Robert, S., Ghislain, R., Johan, R., Christian, D., Lishuang, S., David, S., Philippe, B., Daniel, V., Alexandre, B., Samy, H., Beverley, B., Barbara, H., Guillaume, C., Thomas, J.H., Alexandre, M., Alexey, V.P., Marc, P., Barry, I.P., David, J.B., David, M., Constantin, P., and Philippe, F. (2007). A genomewide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
34. Roses, A.D. (2008). Pharmacogenetics in drug discovery and development: a translational perspective. Nat Rev Drug Discov 7, 807-817.
35. Samter, M., and Beers, R. (1976). Concerning the nature of intolerance to aspirin. J Allergy 40, 281-293.
36. Sanak, M., Kielbasa, B., Bochenek, G., and Szczeklik, A. (2004). Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy 34, 1899-1904.
37. Sistrom, C.L., and Garvan, C.W. (2004). Proportions, odds, and risk. Radiology 230, 12-19.
38. Stevenson, D., Sanchez-Borges, M., and Szczeklik, A. (2001). Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 87, 177-180.
39. Szczeklik, A., Nizankowska, E., and Duplaga, M. (2000). Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma. Eur Respir J 16, 432-436.
40. Wataru, S., Yuko, N., Ikuko, M., Yushi, H., Chiyomi, I., Michiaki, K., Takahisa, K., Tatsuhiko, T., Masahiko, W., Atsushi, T., Hiroyuki, T., Kenji, N., Kazuko, H., Fumiya, O., Takeo, Y., Hideshi, K., Saburo, S., Mitsutoshi, Y., Nobutaka, H., Miho, M., Yusuke, N., and Tatsushi, T. (2009). Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease. Nature Genetics 41, 1303-1307.
41. Willis, C.M., Wrana, J.L., and Kluppel, M. (2009). Identification and characterization of TGFbeta-dependent and -independent cis-regulatory modules in the C4ST-1/CHST11 locus. Genet Mol Res 8, 1331-1343.